Elif Bilge Uysal1, Enver Sancakdar2, Ayşe Şeker3, Köksal Deveci2, Nevin Tuzcu4, Hekim Karapınar5. 1. Department of Microbiology, Faculty of Medicine, Cumhuriyet University Sivas, Turkey. 2. Department of Biochemistry, Faculty of Medicine, Cumhuriyet University Sivas, Turkey. 3. Muhittin Altınok Family Health Center Sivas, Turkey. 4. Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Cumhuriyet University Sivas, Turkey. 5. Department of Cardiology, Faculty of Medicine, Cumhuriyet University Sivas, Turkey.
Abstract
BACKGROUND: Crimean-Congo hemorrhagic fever (CCHF) is known to be associated with cardiac damage. Brain type natriuretic peptide (BNP) is secreted from stressed myocardium. OBJECTIVES: This study investigated that BNP levels in CCHF and its association with clinical course of disease. METHODS: Consecutive CCHF diagnosis confirmed patients were enrolled to the study. Results of patients were compared with age-sex-matched healthy volunteers. Blood samples for BNP levels were collected from the patients during emergency room applications. Mortality, hospitalization duration and other disease severity predictors (thrombocyte count, hemoglobin, white blood cell count, alanine aminotransferase, aspartate aminotransferase, prothrombin time, lactate dehydrogenase, international normalized ratio, activated partial thromboplastin time) were recorded. These parameters' correlations with BNP levels were analyzed. RESULT: Forty-three CCHF patients and 28 control subjects recruited to the study. Groups were similar for age and gender. There was no mortality. Levels of BNP were found to be significantly higher in patients than control subjects (100.4±45.4 vs. 78.0±40.4, P=0.033). But BNP levels were not correlated with duration of hospitalization and disease severity predictors (P > 0.05). CONCLUSIONS: This study showed that BNP levels are modestly increased in CCHF but this increase does not correlated with disease severity predictors.
BACKGROUND:Crimean-Congo hemorrhagic fever (CCHF) is known to be associated with cardiac damage. Brain type natriuretic peptide (BNP) is secreted from stressed myocardium. OBJECTIVES: This study investigated that BNP levels in CCHF and its association with clinical course of disease. METHODS: Consecutive CCHF diagnosis confirmed patients were enrolled to the study. Results of patients were compared with age-sex-matched healthy volunteers. Blood samples for BNP levels were collected from the patients during emergency room applications. Mortality, hospitalization duration and other disease severity predictors (thrombocyte count, hemoglobin, white blood cell count, alanine aminotransferase, aspartate aminotransferase, prothrombin time, lactate dehydrogenase, international normalized ratio, activated partial thromboplastin time) were recorded. These parameters' correlations with BNP levels were analyzed. RESULT: Forty-three CCHF patients and 28 control subjects recruited to the study. Groups were similar for age and gender. There was no mortality. Levels of BNP were found to be significantly higher in patients than control subjects (100.4±45.4 vs. 78.0±40.4, P=0.033). But BNP levels were not correlated with duration of hospitalization and disease severity predictors (P > 0.05). CONCLUSIONS: This study showed that BNP levels are modestly increased in CCHF but this increase does not correlated with disease severity predictors.
Entities:
Keywords:
Crimean-Congo hemorrhagic fever; brain type natriuretic peptide; cardiac damage
Authors: John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher Journal: Eur Heart J Date: 2012-05-19 Impact factor: 29.983
Authors: Ibrahim Gul; Ali Kaya; Ahmet Sami Güven; Hekim Karapinar; Zekeriya Küçükdurmaz; Ahmet Yilmaz; Fusun Dilara Içağasioğlu; Izzet Tandoğan Journal: Med Sci Monit Date: 2011-08
Authors: D Darbar; N C Davidson; N Gillespie; A M Choy; C C Lang; Y Shyr; G P McNeill; T H Pringle; A D Struthers Journal: Am J Cardiol Date: 1996-08-01 Impact factor: 2.778
Authors: Alan Maisel; Christian Mueller; Kirkwood Adams; Stefan D Anker; Nadia Aspromonte; John G F Cleland; Alain Cohen-Solal; Ulf Dahlstrom; Anthony DeMaria; Salvatore Di Somma; Gerasimos S Filippatos; Gregg C Fonarow; Patrick Jourdain; Michel Komajda; Peter P Liu; Theresa McDonagh; Kenneth McDonald; Alexandre Mebazaa; Markku S Nieminen; W Frank Peacock; Marco Tubaro; Roberto Valle; Marc Vanderhyden; Clyde W Yancy; Faiez Zannad; Eugene Braunwald Journal: Eur J Heart Fail Date: 2008-08-29 Impact factor: 15.534